Literature DB >> 20464492

Is there any difference in outcomes between long pigtail and short flanged prophylactic pancreatic duct stents?

Shahzad Iqbal1, Shashin Shah, Vasudha Dhar, Stavros N Stavropoulos, Peter D Stevens.   

Abstract

OBJECTIVE: Prophylactic pancreatic duct (PD) stent placement has been shown to reduce the incidence of post-ERCP pancreatitis (PEP) especially in high-risk patients. However, there is no consensus on the best type of PD stent. The purpose of our study was to evaluate the differences in the outcomes between long (>3 cm) pigtail and short (≤3 cm) flanged 4 Fr Freeman Pancreatic Flexi-Stents in preventing PEP.
METHODS: We retrospectively reviewed all ERCP procedures performed between 08/01/2006 and 10/01/2007 by one of two experienced endoscopists (>5 years of experience) with the assistance of a trainee. Patient data was collected for indications, risk factors for PEP, type and reason for PD stent, complications, and any mortality. The PD stent was removed endoscopically if it was still in place on abdominal X-ray done 2 weeks post-ERCP. The data was analyzed with Student's t test, Chi-square, and ANOVA tests by using SPSS software version 15.0.
RESULTS: Out of a total of 753 ERCP procedures, 179 (23.8%) required either long or short prophylactic PD stents. The incidence of PEP was 3.7% versus 13.6% for long and short stent groups, respectively (p=0.019). Spontaneous stent dislodgement rate was 95.4% versus 81.8% for long and short stent groups, respectively (p=0.007). There was no difference in non-pancreatic complications between the two stent groups. There was no procedure-related mortality.
CONCLUSIONS: Long (>3 cm) pigtail PD stent due to their specific design showed better outcomes as compared to short (<3 cm) flanged PD stent in preventing PEP and spontaneous stent dislodgement rates. However, further prospective trials are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20464492     DOI: 10.1007/s10620-010-1262-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.

Authors:  T Aizawa; N Ueno
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

2.  Risk factors for post-ERCP pancreatitis: a prospective multicenter study.

Authors:  Chi-Liang Cheng; Stuart Sherman; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; Laura Lazzell-Pannell; Abdullah Rashdan; M'hamed Temkit; Glen A Lehman
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

3.  Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.

Authors:  Ananya Das; Pankaj Singh; Michael V Sivak; Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2007-02-28       Impact factor: 9.427

4.  Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.

Authors:  E L Fogel; D Eversman; P Jamidar; S Sherman; G A Lehman
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

5.  Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.

Authors:  Atsushi Sofuni; Hiroyuki Maguchi; Takao Itoi; Akio Katanuma; Hiroyuki Hisai; Teitetsu Niido; Masayuki Toyota; Tsuneshi Fujii; Youji Harada; Tadanori Takada
Journal:  Clin Gastroenterol Hepatol       Date:  2007-11       Impact factor: 11.382

6.  Safety and outcome of endoscopic snare excision of the major duodenal papilla.

Authors:  Ian D Norton; Christopher J Gostout; Todd H Baron; Alex Geller; Bret T Petersen; Maurits J Wiersema
Journal:  Gastrointest Endosc       Date:  2002-08       Impact factor: 9.427

7.  Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.

Authors:  S Sherman; T A Ruffolo; R H Hawes; G A Lehman
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

8.  Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.

Authors:  Martin L Freeman; Carol Overby; Dongfeng Qi
Journal:  Gastrointest Endosc       Date:  2004-01       Impact factor: 9.427

9.  Pancreatic stent prophylaxis of post endoscopic retrograde cholangiopancreatography pancreatitis: spontaneous migration rates and clinical outcomes.

Authors:  P Chahal; T H Baron; B T Petersen; M D Topazian; C J Gostout; M J Levy
Journal:  Minerva Gastroenterol Dietol       Date:  2007-09

10.  Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.

Authors:  Takayoshi Tsuchiya; Takao Itoi; Atsushi Sofuni; Fumihide Itokawa; Toshio Kurihara; Kentaro Ishii; Syujiro Tsuji; Takashi Kawai; Fuminori Moriyasu
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-05-29
View more
  3 in total

1.  The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: A nationwide, register-based study.

Authors:  Greger Olsson; Jeanne Lübbe; Urban Arnelo; Eduard Jonas; Björn Törnqvist; Lars Lundell; Lars Enochsson
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

2.  Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Muhammad S Sajid; Amir H Khawaja; Mazin Sayegh; Krishna K Singh; Zinu Philipose
Journal:  World J Gastrointest Endosc       Date:  2015-12-25

3.  Tumor enucleation with preoperative endoscopic transpapillary stenting for pediatric insulinoma.

Authors:  Shozo Ide; Keiichi Uchida; Mikihiro Inoue; Yuhki Koike; Kohei Otake; Kohei Matsushita; Kiyoshi Hashimoto; Yuka Nagano; Hiroyuki Inoue; Shuji Isaji; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2012-05-11       Impact factor: 1.827

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.